New glucose monitor helps type 2 diabetes patients on insulin

NCT ID NCT06268808

Completed Disease control Sponsor: Abbott Diabetes Care Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether starting the FreeStyle Libre 2 continuous glucose monitor helps adults with type 2 diabetes who use basal insulin. Over three months, researchers measured changes in HbA1c and time spent in healthy blood sugar range. The study included 90 adults aged 18 to 75 with type 2 diabetes for at least one year.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES TREATED WITH INSULIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES TREATED WITH INSULIN

Contacts and locations

Show contact details

Locations

ASL Toscana Nord Ovest

Livorno, Italy
ASL Toscana Nordovest

Carrara, Italy
Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari

Bari, Italy
Azienda Ospedaliero- Universitaria "Renato Dulbecco" di Catanzaro

Catanzaro, Italy
Azienda Ospedaliero-Universitaria di Parma

Parma, Italy
La Sapienza Università di Roma, AOU Policlinico Umberto I

Rome, Italy
Università degli Studi di Catania, Ospedale Garibaldi-Nesima, U.O. Endocrinologia

Catania, Italy
Università degli Studi di Catania, Ospedale Garibaldi-Nesima, U.O.C. Medicina Interna

Catania, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.